Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Unresectable Carcinoma”

1,831 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,831 results

Early research (Phase 1)Looking for participantsNCT05176483
What this trial is testing

Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors

Who this might be right for
Renal Cell Carcinoma (RCC)Metastatic Castration-Resistant Prostate Cancer (mCRPC)Urothelial Carcinoma (UC)+7 more
Exelixis 1,314
Early research (Phase 1)WithdrawnNCT02105350
What this trial is testing

MEK162 With Gemcitabine and Oxaliplatin in Biliary Cancer

Who this might be right for
Biliary Tract CarcinomaGallbladder Carcinoma
University Health Network, Toronto
Testing effectiveness (Phase 2)UnknownNCT03114085
What this trial is testing

Apatinib Combined With Capecitabine Compared With Apatinib Treat Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
First Affiliated Hospital of Guangxi Medical University 170
Early research (Phase 1)UnknownNCT05957640
What this trial is testing

Yttrium-90 Carbon Microspheres in Patients With Unresectable Hepatocellular Carcinoma

Who this might be right for
Unresectable Hepatocellular Carcinoma
Zhongda Hospital 40
Testing effectiveness (Phase 2)Study completedNCT00123825
What this trial is testing

Gemcitabine and Cisplatin for Gallbladder and Biliary Tract Cancer

Who this might be right for
Gallbladder CancerBiliary Tract Cancer
Dana-Farber Cancer Institute 30
Testing effectiveness (Phase 2)UnknownNCT00960518
What this trial is testing

TACE and Adefovir Compared With Transarterial Chemoembolization (TACE) Alone for Hepatitis B Virus (HBV)-Related Unresectable Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatitis B VirusHepatocellular Carcinoma
Tongji University 216
Not applicableLooking for participantsNCT07024680
What this trial is testing

Real World Study of Effectiveness of Sunitinib or Sorafenib to Chinese Unresectable Locally Advanced or Metastatic PRCC

Who this might be right for
Papillary Renal Cell Carcinoma
AstraZeneca 150
Testing effectiveness (Phase 2)Study completedNCT02761057
What this trial is testing

Testing Cabozantinib, Crizotinib, Savolitinib and Sunitinib in Kidney Cancer Which Has Progressed

Who this might be right for
Locally Advanced Papillary Renal Cell CarcinomaMetastatic Papillary Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v7+4 more
National Cancer Institute (NCI) 152
Testing effectiveness (Phase 2)Study completedNCT00609401
What this trial is testing

Study Comparing Association Between Sorafenib and Interleukin-2 (IL-2) Versus Sorafenib in 1st Line Therapy in Advanced (Adv) Renal Cell Carcinoma (RCC)

Who this might be right for
Metastatic DiseaseRenal Cell Carcinoma
Italian Trial in Medical Oncology 90
Large-scale testing (Phase 3)Ended earlyNCT04866017
What this trial is testing

Compare Ociperlimab Plus Tislelizumab Versus Durvalumab Following Concurrent Chemoradiotherapy (cCRT) in Participants With Stage III Unresectable Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
BeiGene 63
Testing effectiveness (Phase 2)Study completedNCT01900002
What this trial is testing

Sorafenib Tosylate and Yttrium Y 90 Glass Microspheres in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Who this might be right for
Advanced Adult Hepatocellular CarcinomaBCLC Stage C Hepatocellular CarcinomaRecurrent Adult Hepatocellular Carcinoma+8 more
M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)UnknownNCT05029973
What this trial is testing

HAIC Combined With Sintilimab and Bevacizumab Biosimilar for Unresectable HCC

Who this might be right for
Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 30
Early research (Phase 1)Study completedNCT01008566
What this trial is testing

Cixutumumab and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer

Who this might be right for
Adult Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaLocalized Non-Resectable Adult Liver Carcinoma+1 more
National Cancer Institute (NCI) 21
Testing effectiveness (Phase 2)Study completedNCT04732494
What this trial is testing

Anti-PD-1 Monoclonal Antibody Tislelizumab (BGB-A317) Combined With or Without Anti-TIGIT Monoclonal Antibody Ociperlimab (BGB-A1217) in Participants With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
BeiGene 125
Testing effectiveness (Phase 2)Active Not RecruitingNCT05901194
What this trial is testing

Lenvatinib Treatment in Waiting List of Liver Transplantation After TACE Failure in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Assistance Publique - Hôpitaux de Paris 25
Large-scale testing (Phase 3)Looking for participantsNCT05058651
What this trial is testing

Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung

Who this might be right for
Advanced Extrapulmonary Neuroendocrine CarcinomaMetastatic Extrapulmonary Neuroendocrine CarcinomaRecurrent Extrapulmonary Neuroendocrine Carcinoma+1 more
National Cancer Institute (NCI)
Not applicableNot Yet RecruitingNCT07340502
What this trial is testing

TACE Versus HAIC, Combined With PD-1 Inhibitors and Lenvatinib for Unresectable Hepatocellular Carcinoma

Who this might be right for
HCC
Tongji Hospital 364
Testing effectiveness (Phase 2)Study completedNCT00956930
What this trial is testing

Chemoembolization Versus Radioembolization in Treating Patients With Liver Cancer That Cannot Be Treated With Radiofrequency Ablation Or Surgery

Who this might be right for
Liver Cancer
Northwestern University 45
Early research (Phase 1)Study completedNCT00003439
What this trial is testing

Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)Ended earlyNCT00271323
What this trial is testing

Safety Study of Docetaxel/Cisplatin Induction Therapy Followed by Concurrent Chemoradiotherapy or Concurrent Chemoradiotherapy Followed by Consolidation Docetaxel/Cisplatin in NSCLC Patients

Who this might be right for
Non-Small-Cell Lung Carcinoma
Sanofi 14
Load More Results
189